The Saudi Biobank, Saudi Arabia

Certification Status: Documents Required

Registration Status: Completed

Objective: The Saudi Biobank is a national project that is shepherded by King Abdullah International Medical Research Center (KAIMRC). It will serve as a vital footstep towards building a biobanking platform for our kingdomâ€™s population. It will provide valuable resources for conducting cutting edge medical research with a focus on the Saudi health priorities and improving health outcomes. The project aims to enroll 200,000 participants with in-depth knowledge regarding phenotypes using a variety of biological samples, which are collected, stored and processed by state-of-the-art automated facilities. This project aims to support a wide range of genetic and epidemiological research studies that are focused on improving the preventive, diagnostic, and treatment of common and rare diseases in KSA. The Saudi Biobank provides resources for conducting medical and clinical researchers. These resources include clinical and socio-demographic data as well as biological materials. They are collected by well-trained staff and processed, stored and maintained by fully automated systems. Samples and data can be retrieved automatically to ensure the high quality of data as well as maintaining participantâ€™s privacy and confidentiality. The Saudi Biobank is one of the important medical research projects in the Kingdom of Saudi Arabia to study the impact of a healthy lifestyle, genes and the environment in the Saudi population.

Registered Biobank Name	The Saudi Biobank
Biobank Leader	Dr. Jahad Alghamdi
Country	Saudi Arabia
Email for biobank inquiries	Kaimrc-Biobank@ngha.med.sa
Principal Investigator	Dr. Ahmed Alaskar
Website	http://kaimrc.med.sa/
User Type Mono: A biobank that supports a specific research project, may have few staff members, a small-scale accrual scope with little to no initial intention of releasing or distributing biospecimens to secondary parties Oligo: A biobank that supports several research groups or clinical trials, may or may not be designed to release biospecimens outside their collaborative group Poly: A biobank that has generally a larger accrual scope, resources, and multiple users outside the biobank proper	Poly - Collection aimed at supporting undetermined, multiple users with ethics approved research projects, through a defined access/application mechanism.

Biospecimen Collected:

Cohort Highlights

100 cases Next Generation Sequencing assay to detect all classes of genetic variant in Lung Cancer using a single Diagnostic test.
200 cases Colorectal TMA for QC purposes in support of study of tumor infiltrating lymphocytes in ovarian cancer tissues.
Build 300 cases breast cancer TMA containing primary tumour and matched metastatic LN for various subtypes (luminal, HER2, Triple negative). Start with Triple negatives.
125 cases Breast tumour and metastatic lymph nodes in breast cancer cases with outcomes of metastasis to lung or bone.
100 cases of rare tumours - fibrolamellar hepatocellular carcinoma. FFPE, frozen, BC.
200 cases of FFPE tissue sections from breast, lung adenocarcinoma, and lung squamous cell carcinoma with matching normal tissue (only pathology data requested).